Lista de obras - Clotilde Allavena - Dominio Público Uruguay

A large French prospective cohort of HIV-infected patients: the Nadis Cohort.

artículo científico publicado en 2009

A randomized, open-label study of a nucleoside analogue reverse transcriptase inhibitor-sparing regimen in antiretroviral-naive HIV-infected patients

artículo científico publicado en 2009

A single HIV-1 cluster and a skewed immune homeostasis drive the early spread of HIV among resting CD4+ cell subsets within one month post-infection

artículo científico publicado en 2013

Acceptability and confidence in antiretroviral generics of physicians and HIV-infected patients in France

artículo científico publicado en 2014

Antiretroviral exposure and comorbidities in an aging HIV-infected population: The challenge of geriatric patients

artículo científico publicado en 2018

Antiretroviral therapy as a risk factor for chronic kidney disease: Results from traditional regression modeling and causal approach in a large observational study.

artículo científico publicado en 2017

Blood Telomere Length Changes After Ritonavir-Boosted Darunavir Combined With Raltegravir or Tenofovir-Emtricitabine in Antiretroviral-Naive Adults Infected With HIV-1

article

Boosted protease inhibitor-based or nonnucleoside reverse transcriptase-based HAART: is there a best choice for antiretroviral-naive HIV-1 infected patients?

artículo científico publicado en 2008

CMV+ Serostatus Associates Negatively with CD4:CD8 Ratio Normalization in Controlled HIV-Infected Patients on cART.

artículo científico publicado en 2016

COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study

artículo científico publicado en 2021

Can the “Seek, Test, Treat, and Retain” Strategy be Effective in France? ⬇️

artículo científico publicado el 1 de abril de 2013

Clinical relevance of the interaction when switching non-nucleoside reverse transcriptase inhibitors in patients infected with HIV.

artículo científico

Combined ART started during acute HIV infection protects central memory CD4+ T cells and can induce remission

artículo científico publicado en 2015

Comparative Effectiveness of First Antiretroviral Regimens in Clinical Practice Using a Causal Approach

artículo científico publicado en 2015

Derivation and internal validation of a mortality risk index for aged people living with HIV: The Dat'AIDS score.

artículo científico publicado en 2018

Despite an impaired response to IL-7, CD4+EM T cells from HIV-positive patients proliferate normally in response to IL-15 and its superagonist, RLI.

artículo científico publicado en 2011

Disturbance of apolipoprotein B100 containing lipoprotein metabolism in severe hyperlipidemic and lipodystrophic HIV patients on combined antiretroviral therapy: evidences of insulin resistance effect

artículo científico publicado en 2008

Does first-line antiretroviral regimen impact risk for chronic kidney disease whatever the risk group?

artículo científico publicado en 2016

Effect of Efavirenz, Nevirapine, Etravirine, and Raltegravir Administration on the Pharmacokinetics of Ritonavir-Boosted Darunavir in a Population of HIV-Infected Patients ⬇️

artículo científico publicado el 16 de diciembre de 2012

Effectiveness and tolerance of single tablet versus once daily multiple tablet regimens as first-line antiretroviral therapy - Results from a large french multicenter cohort study

artículo científico publicado en 2017

Efficacy and tolerability of Etravirine in HIV-1 adult patients: Results of a large French prospective cohort

artículo científico publicado en 2014

Efficacy and tolerability of a nucleoside reverse transcriptase inhibitor-sparing combination of lopinavir/ritonavir and efavirenz in HIV-1-infected patients

artículo científico publicado en 2005

Epidemiology of autoimmune and inflammatory diseases in a French Nationwide HIV cohort.

artículo científico publicado en 2017

Evaluation of residual viremia and quantitation of soluble CD14 in a large cohort of HIV‐infected adults on a long‐term non‐nucleoside reverse transcriptase inhibitor‐based regimen ⬇️

artículo científico publicado el 16 de julio de 2013

First-line cART regimen impacts the course of CD8+ T-cell counts in HIV-infected patients that achieve sustained undetectable viral load

scientific article published on October 2016

High syphilis prevalence and incidence in people living with HIV and Preexposure Prophylaxis users: A retrospective review in the French Dat'AIDS cohort

artículo científico publicado en 2022

Human immunodeficiency virus infection and non-small cell lung cancer: survival and toxicity of antineoplastic chemotherapy in a cohort study

artículo científico publicado en 2011

Impact of baseline plasma HIV-1 RNA and time to virological suppression on virological rebound according to first-line antiretroviral regimen

artículo científico publicado en 2017

Impact of baseline plasma HIV-1 RNA and time to virological suppression on virological rebound according to ﬁrst-line antiretroviral regimen

artículo científico publicado en 2017

Impact of education and support on the tolerability and quality of life in a cohort of HIV-1 infected patients treated with enfuvirtide (SURCOUF Study).

artículo científico publicado en 2008

Incidence and risk factors for liver enzymes elevations in highly treatment-experienced patients switching from enfuvirtide to raltegravir: a sub-study of the ANRS-138 EASIER trial

artículo científico publicado en 2016

Influence of nevirapine administration on the pharmacokinetics of dolutegravir in patients infected with HIV-1.

artículo científico

Latent Tuberculosis Infection Screening and 2-Year Outcome in Antiretroviral-Naive HIV-Infected Patients in a Low-Prevalence Country

artículo científico publicado en 2015

Levels of intracellular HIV-DNA in patients with suppressive antiretroviral therapy

artículo científico publicado en 2015

Long-term efficacy and safety of etravirine-containing regimens in a real-life cohort of treatment-experienced HIV-1-infected patients

artículo científico publicado en 2016

Neuropsychiatric adverse events after switching from an antiretroviral regimen containing efavirenz without tenofovir to an efavirenz regimen containing tenofovir: a report of nine cases.

artículo científico publicado en 2006

Nevirapine-raltegravir combination, an NRTI and PI/r sparing regimen, as maintenance antiretroviral therapy in virologically suppressed HIV-1-infected patients

artículo científico

No significant influence of saquinavir hard-gel capsule administration on pharmacokinetics of lopinavir in combination with ritonavir: a population approach

artículo científico publicado en 2005

Optimizing the virological success of tenofovir DF/FTC/rilpivirine in HIV-infected naive and virologically suppressed patients through strict clinical and virological selection

artículo científico

Perception of antiretroviral generic medicines: one-day survey of HIV-infected patients and their physicians in France

artículo científico publicado en 2015

Pharmacokinetic evidence for the induction of lopinavir metabolism by efavirenz

artículo científico publicado en 2005

Prevalence and risk factors of sleep disturbances in a large HIV-infected adult population

artículo científico publicado en 2014

Raltegravir becomes a once daily antiretroviral

artículo científico publicado en 2017

Residual viremia in patients on antiretroviral therapy incorporating nevirapine is not associated with the gag-specific cellular immune response

artículo científico publicado en 2013

Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial

artículo científico publicado en 2014

Spectrum and incidence trends of AIDS and non-AIDS defining cancers between 2010-2015 in the French Dat'AIDS cohort

scientific article published on 11 December 2020

The Immune Response to the RT181-189 Epitope in HIV-1-Infected Patients is Associated with Viral Sequence Polymorphism Flanking the Epitope ⬇️

artículo científico publicado el 14 de abril de 2011

The value of open-source clinical science in pandemic response: lessons from ISARIC

artículo científico publicado en 2021

Tipranavir in highly antiretroviral treatment-experienced patients: Results from a French prospective cohort

article

Virological response to darunavir in patients infected with HIV is linked to darunavir resistance-associated mutations corrected by the count of mutations with positive impact and is not associated with pharmacological and combined virological/pharm

artículo científico publicado en 2011

Lista de obras de Clotilde Allavena

A large French prospective cohort of HIV-infected patients: the Nadis Cohort.

A randomized, open-label study of a nucleoside analogue reverse transcriptase inhibitor-sparing regimen in antiretroviral-naive HIV-infected patients

A single HIV-1 cluster and a skewed immune homeostasis drive the early spread of HIV among resting CD4+ cell subsets within one month post-infection

Acceptability and confidence in antiretroviral generics of physicians and HIV-infected patients in France

Antiretroviral exposure and comorbidities in an aging HIV-infected population: The challenge of geriatric patients

Antiretroviral therapy as a risk factor for chronic kidney disease: Results from traditional regression modeling and causal approach in a large observational study.

Blood Telomere Length Changes After Ritonavir-Boosted Darunavir Combined With Raltegravir or Tenofovir-Emtricitabine in Antiretroviral-Naive Adults Infected With HIV-1

Boosted protease inhibitor-based or nonnucleoside reverse transcriptase-based HAART: is there a best choice for antiretroviral-naive HIV-1 infected patients?

CMV+ Serostatus Associates Negatively with CD4:CD8 Ratio Normalization in Controlled HIV-Infected Patients on cART.

COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study

Can the “Seek, Test, Treat, and Retain” Strategy be Effective in France? ⬇️

Clinical relevance of the interaction when switching non-nucleoside reverse transcriptase inhibitors in patients infected with HIV.

Combined ART started during acute HIV infection protects central memory CD4+ T cells and can induce remission

Comparative Effectiveness of First Antiretroviral Regimens in Clinical Practice Using a Causal Approach

Derivation and internal validation of a mortality risk index for aged people living with HIV: The Dat'AIDS score.

Despite an impaired response to IL-7, CD4+EM T cells from HIV-positive patients proliferate normally in response to IL-15 and its superagonist, RLI.

Disturbance of apolipoprotein B100 containing lipoprotein metabolism in severe hyperlipidemic and lipodystrophic HIV patients on combined antiretroviral therapy: evidences of insulin resistance effect

Does first-line antiretroviral regimen impact risk for chronic kidney disease whatever the risk group?

Effect of Efavirenz, Nevirapine, Etravirine, and Raltegravir Administration on the Pharmacokinetics of Ritonavir-Boosted Darunavir in a Population of HIV-Infected Patients ⬇️

Effectiveness and tolerance of single tablet versus once daily multiple tablet regimens as first-line antiretroviral therapy - Results from a large french multicenter cohort study

Efficacy and tolerability of Etravirine in HIV-1 adult patients: Results of a large French prospective cohort

Efficacy and tolerability of a nucleoside reverse transcriptase inhibitor-sparing combination of lopinavir/ritonavir and efavirenz in HIV-1-infected patients

Epidemiology of autoimmune and inflammatory diseases in a French Nationwide HIV cohort.

Evaluation of residual viremia and quantitation of soluble CD14 in a large cohort of HIV‐infected adults on a long‐term non‐nucleoside reverse transcriptase inhibitor‐based regimen ⬇️

First-line cART regimen impacts the course of CD8+ T-cell counts in HIV-infected patients that achieve sustained undetectable viral load

High syphilis prevalence and incidence in people living with HIV and Preexposure Prophylaxis users: A retrospective review in the French Dat'AIDS cohort

Human immunodeficiency virus infection and non-small cell lung cancer: survival and toxicity of antineoplastic chemotherapy in a cohort study

Impact of baseline plasma HIV-1 RNA and time to virological suppression on virological rebound according to first-line antiretroviral regimen

Impact of baseline plasma HIV-1 RNA and time to virological suppression on virological rebound according to ﬁrst-line antiretroviral regimen

Impact of education and support on the tolerability and quality of life in a cohort of HIV-1 infected patients treated with enfuvirtide (SURCOUF Study).

Incidence and risk factors for liver enzymes elevations in highly treatment-experienced patients switching from enfuvirtide to raltegravir: a sub-study of the ANRS-138 EASIER trial

Influence of nevirapine administration on the pharmacokinetics of dolutegravir in patients infected with HIV-1.

Latent Tuberculosis Infection Screening and 2-Year Outcome in Antiretroviral-Naive HIV-Infected Patients in a Low-Prevalence Country

Levels of intracellular HIV-DNA in patients with suppressive antiretroviral therapy

Long-term efficacy and safety of etravirine-containing regimens in a real-life cohort of treatment-experienced HIV-1-infected patients

Neuropsychiatric adverse events after switching from an antiretroviral regimen containing efavirenz without tenofovir to an efavirenz regimen containing tenofovir: a report of nine cases.

Nevirapine-raltegravir combination, an NRTI and PI/r sparing regimen, as maintenance antiretroviral therapy in virologically suppressed HIV-1-infected patients

No significant influence of saquinavir hard-gel capsule administration on pharmacokinetics of lopinavir in combination with ritonavir: a population approach

Optimizing the virological success of tenofovir DF/FTC/rilpivirine in HIV-infected naive and virologically suppressed patients through strict clinical and virological selection

Perception of antiretroviral generic medicines: one-day survey of HIV-infected patients and their physicians in France

Pharmacokinetic evidence for the induction of lopinavir metabolism by efavirenz

Prevalence and risk factors of sleep disturbances in a large HIV-infected adult population

Raltegravir becomes a once daily antiretroviral

Residual viremia in patients on antiretroviral therapy incorporating nevirapine is not associated with the gag-specific cellular immune response

Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial

Spectrum and incidence trends of AIDS and non-AIDS defining cancers between 2010-2015 in the French Dat'AIDS cohort

The Immune Response to the RT181-189 Epitope in HIV-1-Infected Patients is Associated with Viral Sequence Polymorphism Flanking the Epitope ⬇️

The value of open-source clinical science in pandemic response: lessons from ISARIC

Tipranavir in highly antiretroviral treatment-experienced patients: Results from a French prospective cohort

Virological response to darunavir in patients infected with HIV is linked to darunavir resistance-associated mutations corrected by the count of mutations with positive impact and is not associated with pharmacological and combined virological/pharm